China
StepStone adds partner in Beijing
StepStone Group, a provider of private markets advisory and asset management services to institutional investors, has promoted Beijing-based Vincent Hsu to partner.
Deal focus: From space food to sustainable food
Sustainable Bioproducts left stealth mode to raise a $33 million Series A round as it targets commercialization for an edible protein technology that won early backing from NASA
Vision Knight backs Chinese personal care products maker
Vision Knight Capital has led a RMB200 million ($29 million) Series C round for Soocas, a Shenzhen-based manufacturer of personal care products such as electric toothbrushes and hairdryers.
C-Bridge helps Korea's Samsung Bioepis with China expansion
C-Bridge Capital has announced a licensing agreement with Samsung Bioepis that is intended to help the Korean biopharmaceutical specialist expand into the China market.
Huagai leads $146m round for China’s HaiHe Biopharma
Shanghai-based cancer drug developer HaiHe Biopharma has raised $146.6 million in a funding round led by Chinese private equity firm Huagai Capital.
Chinese auto parts supplier raises $25m in Series A
Mancando, an automotive parts supplier based in Guangdong province, has raised RMB170 million ($25 million) in Series A funding led by Eastern Bell Venture Capital, with participation from Legend Capital.
IDG, Lilly join $10m round for China’s EdiGene
IDG Capital and Lilly Asia Ventures (LAV) have joined a $10 million investment in EdiGene, a developer of genetics-based therapies based in Beijing.
PE-backed ticketing player falls on debut after $287m HK IPO
Maoyan Entertainment, a Chinese online movie ticketing business backed by Tencent Holdings and several private equity investors, fell on its trading debut in Hong Kong following a HK$2.25 billion ($287.1 million) IPO.
Ascendent sets $800m target for third China fund
Ascendent Capital Partners is seeking $800 million for its third China mid-market fund. The GP closed its previous vehicle at $600 million in 2015.
China distress: Second cycle
Investors are looking to capitalize on the China distress opportunity, and recent activity in around non-performing loans suggests there will be enough deal flow to sate their appetites
Fund focus: Redpoint China leverages its brand
Redpoint China Ventures secures $400 million for its traditional early-stage investments as well as for an expansion into growth round coverage
China reveals qualification criteria for Shanghai tech board listings
China has unveiled details of the highly anticipated new technology and innovation board, which is set to adopt a registration-based system that should allow a shorter route to liquidity for PE and VC investors.
Matrix China leads $60m round for Nasn Automotive
Shanghai-based Nasn Automotive, a manufacturer of vehicle wiring and brake systems, has raised RMB400 million ($60 million) in a Series B round of funding led by Matrix Partners China.
Chinese industrial waste processor raises $37m Series A
Ningbo-based industrial hazardous waste processor Nuoke Huanjing Keji has raised RMB250 million ($37.2 million) in a Series A round of funding participated by US-China Green Fund and Avic Trust.
Chinese satellite developer receives $37m angel round
Chang Guang Satellite Technology, a China-based commercial satellite developer, has raised RMB250 million ($37 million) in angel funding, underlining growing investor interest in space-related technology.
Internal affairs: China VCs and relationship management
Recent troubles in China’s autonomous driving space highlight the challenges venture capital investors face in picking the right founders to back and then managing those relationships in a productive way
Deal focus: Advent sees potential in hybrid CRO
Advent International recognized BioDuro as a company uniquely positioned to leverage growth in pharmaceutical R&D outsourcing in China and the US
GP due diligence: Stones unturned
The expansion of private equity activity in developing markets is translating into greater due diligence pressure on LPs seeking reliable fund managers. Solutions are intuitive but difficult
ClearVue targets $600m for third China consumer fund
China consumer-focused private equity firm ClearVue Partners is seeking to raise $600 million for its third fund. It comes nearly two years after the GP closed Fund II at $362 million.
China supply chain solutions provider gets $356m Series A
Shenzhen-based Zhunshida, or Jusida, a logistics spin-out from Foxconn International, has raised RMB2.4 billion ($355.8 million) in Series A funding led by China Life Insurance.
LionRock buys stake in Italian football club Inter Milan
Asian private equity investor LionRock Capital has agreed to buy a minority stake in Italian football club Internazionale Milano (Inter Milan), which has been controlled by Chinese electronics retailer Suning since 2016.
CITIC Capital targets China distress
CITIC Capital has established a team to make distressed investments in China, primarily in the real estate sector, and is considering raising a fund dedicated to this strategy.
Advent buys majority stake in US, China-based BioDuro
Advent International has acquired a majority stake in BioDuro, a pharmaceutical contract research and development organization (CRO) with operations in the US and China, from the Bridgewest Group conglomerate.
BP Ventures backs China EV player
BP Ventures, the venture capital arm of BP, has made its first investment in China, leading a Series A round for electric vehicle (EV) charging solutions provider PowerShare.